Home › Pancreatic Ductal Carcinoma › Virginia
Pancreatic Ductal Carcinoma clinical trials in Virginia
3 studies for Pancreatic Ductal Carcinoma are looking for participants at sites in Virginia.
Cities in Virginia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Virginia Cancer Specialists, Fairfax
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NEXT Oncology Virginia, Fairfax
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Next Oncology Virginia, Fairfax
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.